110 related articles for article (PubMed ID: 16272158)
1. Binding of PAI-1 to endothelial cells stimulated by thymosin beta4 and modulation of their fibrinolytic potential.
Boncela J; Smolarczyk K; Wyroba E; Cierniewski CS
J Biol Chem; 2006 Jan; 281(2):1066-72. PubMed ID: 16272158
[TBL] [Abstract][Full Text] [Related]
2. Ku80 as a novel receptor for thymosin beta4 that mediates its intracellular activity different from G-actin sequestering.
Bednarek R; Boncela J; Smolarczyk K; Cierniewska-Cieslak A; Wyroba E; Cierniewski CS
J Biol Chem; 2008 Jan; 283(3):1534-1544. PubMed ID: 17984099
[TBL] [Abstract][Full Text] [Related]
3. Thymosin beta 4 induces the synthesis of plasminogen activator inhibitor 1 in cultured endothelial cells and increases its extracellular expression.
Al-Nedawi KN; Czyz M; Bednarek R; Szemraj J; Swiatkowska M; Cierniewska-Cieslak A; Wyczolkowska J; Cierniewski CS
Blood; 2004 Feb; 103(4):1319-24. PubMed ID: 14592829
[TBL] [Abstract][Full Text] [Related]
4. TM5275 prolongs secreted tissue plasminogen activator retention and enhances fibrinolysis on vascular endothelial cells.
Yasui H; Suzuki Y; Sano H; Suda T; Chida K; Dan T; Miyata T; Urano T
Thromb Res; 2013 Jul; 132(1):100-5. PubMed ID: 23611258
[TBL] [Abstract][Full Text] [Related]
5. Regulation of the fibrinolytic potential of cultured human umbilical vein endothelial cells: astragaloside IV downregulates plasminogen activator inhibitor-1 and upregulates tissue-type plasminogen activator expression.
Zhang WJ; Wojta J; Binder BR
J Vasc Res; 1997; 34(4):273-80. PubMed ID: 9256087
[TBL] [Abstract][Full Text] [Related]
6. Thrombin stimulates increased plasminogen activator inhibitor-1 release from liver compared to lung endothelium.
Huebner BR; Moore EE; Moore HB; Gonzalez E; Kelher MR; Sauaia A; Banerjee A; Silliman CC
J Surg Res; 2018 May; 225():1-5. PubMed ID: 29605018
[TBL] [Abstract][Full Text] [Related]
7. Vimentin exposed on activated platelets and platelet microparticles localizes vitronectin and plasminogen activator inhibitor complexes on their surface.
Podor TJ; Singh D; Chindemi P; Foulon DM; McKelvie R; Weitz JI; Austin R; Boudreau G; Davies R
J Biol Chem; 2002 Mar; 277(9):7529-39. PubMed ID: 11744725
[TBL] [Abstract][Full Text] [Related]
8. Regulation of plasminogen activator inhibitor activity by plasmin in endothelial cells.
Shi GY; Wang SJ; Chang B; Tasi CF; Lin MT; Chang WC; Wing LY; Jen CJ; Wu HL
Thromb Res; 1996 Jan; 81(1):75-84. PubMed ID: 8747522
[TBL] [Abstract][Full Text] [Related]
9. Thymosin β4 promotes the migration of endothelial cells without intracellular Ca2+ elevation.
Selmi A; Malinowski M; Brutkowski W; Bednarek R; Cierniewski CS
Exp Cell Res; 2012 Aug; 318(14):1659-66. PubMed ID: 22652458
[TBL] [Abstract][Full Text] [Related]
10. Regenerative protein thymosin beta-4 is a novel regulator of purinergic signaling.
Freeman KW; Bowman BR; Zetter BR
FASEB J; 2011 Mar; 25(3):907-15. PubMed ID: 21106936
[TBL] [Abstract][Full Text] [Related]
11. Plasminogen activator inhibitor-1 promotes formation of endothelial microparticles with procoagulant potential.
Brodsky SV; Malinowski K; Golightly M; Jesty J; Goligorsky MS
Circulation; 2002 Oct; 106(18):2372-8. PubMed ID: 12403669
[TBL] [Abstract][Full Text] [Related]
12. A novel antithrombotic role for high molecular weight kininogen as inhibitor of plasminogen activator inhibitor-1 function.
Chavakis T; Pixley RA; Isordia-Salas I; Colman RW; Preissner KT
J Biol Chem; 2002 Sep; 277(36):32677-82. PubMed ID: 12082110
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor-alpha and troglitazone regulate plasminogen activator inhibitor type 1 production through extracellular signal-regulated kinase- and nuclear factor-kappaB-dependent pathways in cultured human umbilical vein endothelial cells.
Hamaguchi E; Takamura T; Shimizu A; Nagai Y
J Pharmacol Exp Ther; 2003 Dec; 307(3):987-94. PubMed ID: 14534369
[TBL] [Abstract][Full Text] [Related]
14. Characterization of immortalized human umbilical and iliac vein endothelial cell lines after transfection with SV40 large T-antigen.
van Leeuwen EB; Veenstra R; van Wijk R; Molema G; Hoekstra A; Ruiters MH; van der Meer J
Blood Coagul Fibrinolysis; 2000 Jan; 11(1):15-25. PubMed ID: 10691096
[TBL] [Abstract][Full Text] [Related]
15. Pro- and antifibrinolytic properties of human pulmonary microvascular versus artery endothelial cells: impact of endotoxin and tumor necrosis factor-alpha.
Muth H; Maus U; Wygrecka M; Lohmeyer J; Grimminger F; Seeger W; Günther A
Crit Care Med; 2004 Jan; 32(1):217-26. PubMed ID: 14707582
[TBL] [Abstract][Full Text] [Related]
16. Immunoelectron microscopic localization of type 1 plasminogen activator inhibitor on the surface of activated endothelial cells.
Schleef RR; Loskutoff DJ; Podor TJ
J Cell Biol; 1991 Jun; 113(6):1413-23. PubMed ID: 2045419
[TBL] [Abstract][Full Text] [Related]
17. Function-stabilizing mechanism of plasminogen activator inhibitor type 1 induced upon binding to alpha1-acid glycoprotein.
Smolarczyk K; Gils A; Boncela J; Declerck PJ; Cierniewski CS
Biochemistry; 2005 Sep; 44(37):12384-90. PubMed ID: 16156651
[TBL] [Abstract][Full Text] [Related]
18. Binding of tissue plasminogen activator to human endothelial cells. Importance of the B-chain as a ligand.
Cheng XF; Bäck O; Nilsson TK; Nylander Lundqvist E; Pohl G; Wallén P
Biochem J; 1992 Oct; 287 ( Pt 2)(Pt 2):407-13. PubMed ID: 1332673
[TBL] [Abstract][Full Text] [Related]
19. Cathepsin G--induced release of PAI-1 in the culture medium of endothelial cells: a new thrombogenic role for polymorphonuclear leukocytes?
Pintucci G; Iacoviello L; Castelli MP; Amore C; Evangelista V; Cerletti C; Donati MB
J Lab Clin Med; 1993 Jul; 122(1):69-79. PubMed ID: 8320493
[TBL] [Abstract][Full Text] [Related]
20. Plasminogen activator inhibitor type-1 mutants regulate angiogenesis of human umbilical and lung vascular endothelial cells.
Chorostowska-Wynimko J; Swiercz R; Skrzypczak-Jankun E; Selman SH; Jankun J
Oncol Rep; 2004 Dec; 12(6):1155-62. PubMed ID: 15547731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
